FDA Panel Votes in Favor of Olodaterol for COPD – Medscape


Medscape

FDA Panel Votes in Favor of Olodaterol for COPD
Medscape
Dr. Tracy, assistant professor of internal medicine at Creighton University School of Medicine, Omaha, Nebraska, listed his reasons: "Background medications, spectrum of disease severity, real-world setting, all the endpoints were met." Exercise
FDA Advisory Committee Recommends Approval for Boehringer Ingelheim's PharmaLive (press release) (subscription)

all 9 news articles »

View full post on world asthma day – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *